Oral formulations of metronidazole and methods of treating an infection using same
AssigneeAppili Therapeutics Inc.
InventorsBernard J. Guarino, Jr., Jamie L. Doran, Zorana Radovic, Kevin Sullivan
Life of this patent
Estimating the term…
Abstract
The present disclosure provides oral pharmaceutical compositions comprising: 1) metronidazole or a pharmaceutically acceptable salt thereof; and magnesium aluminum silicate; or 2) metronidazole or a pharmaceutically acceptable salt thereof; magnesium aluminum silicate; and a flavoring agent. Methods of treating infection utilizing the oral pharmaceutical compositions are also provided.
Claims21
An oral pharmaceutical composition comprising a) metronidazole or a pharmaceutically acceptable salt thereof;
- and b) magnesium aluminum silicate.
An oral pharmaceutical composition comprising a) metronidazole or a pharmaceutically acceptable salt thereof;
- b) magnesium aluminum silicate;
- c) and at least one flavoring agent.
An oral pharmaceutical composition comprising:
- metronidazole, sucrose, glycerin, purified water, magnesium aluminum silicate, microcrystalline cellulose, sucralose, sodium phosphate, one or more preservatives, strawberry flavoring agent and peppermint flavoring agent.
A method of treating an infection in a patient, said method comprising the step of administering to the patient an effective amount of an oral pharmaceutical composition comprising:
- a) metronidazole or a pharmaceutically acceptable salt thereof and magnesium aluminum silicate;
- or
- b) metronidazole or a pharmaceutically acceptable salt thereof;
- magnesium aluminum silicate;
- and at least one flavoring agent.
Dependencies are inferred from the claim text.